EWTX · Edgewise Therapeutics, Inc.
$43.29
-3.15 (-6.78%)
At close · Aug 20
Market Cap
$5.02B
Shares
108.60M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$43.29
Open$45.91
Day$43.08–45.91
52W close$13.70–48.35
Avg vol 30d1.2M
Short int9.8M · 9.1% float · 12.1d
Short vol68%
Last earningsMay 13, 2024
DataMar 2021–Aug 2026
Filing10-Q · Aug 6
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+37%
above
Price vs 50-day avg
+6%
above
RSI (14)
52
neutral
MACD trend
Positive
52-week position
85%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+10%
trailing
6-month return
+42%
trailing
YTD return
+74%
this year
Relative strength
+31%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $41 › 200d $32 — 50d above 200d
Institutional flow
Accumulating
+4% holders QoQ · +40 funds added
Insider flow
Distributing
Net -$785.0K over 90 days · 100% sells
Short interest
Falling
9.06% of float · ▼ -2.4% MoM · 12.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
225 holders — near 3-yr high, broad support
Squeeze score
79
high risk · 0–100
Fundamentals
EPS growth
−12%
Y/Y
Free cash flow
$-144.1M
Balance sheet
$61.1M
net cash
Quant / Vol
risk profile
Volatility
78%
annualized · 1-yr
Max drawdown
−21%
past year
ATR
5.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+37%
Bullish
Price vs 50-day avg
+6%
Bullish
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
85%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $41 › 200d $32 — 50d above 200d
Institutional flow
Accumulating
+4% holders QoQ · +40 funds added
Insider flow
Distributing
Net -$785.0K over 90 days · 100% sells
Short interest
Falling
9.06% of float · ▼ -2.4% MoM · 12.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
225 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $14
Now $43 · 85%
Range high $48
vs 200-day avg +37%
vs 50-day avg +6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EWTX
this stock
Edgewise Therapeutics, Inc.
|
$5.02B | +74.5% | — | — | 9.1% |
|
ONC
BeOne Medicines Ltd.
|
$557.05B | +21.5% | +22179.2% | 856.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
MRNA
Moderna, Inc.
|
$69.62B | +352.1% | +4.3% | — | 12.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EWTX | +0.3% | +10.2% | +42.2% | +12.7% | +74.5% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +2.2% | +6.9% | +31.0% | +10.6% | +62.6% |
Key facts
CIK
1710072
CUSIP
28036F105
13F (30d)
212 filings
208 filers
Visit website
Investor relations